Research Paper Volume 11, Issue 3 pp 1019—1029

A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy

class="figure-viewer-img"

Figure 2. Schematic representation of position of CHST6 variants and its protein domains. The sulfotransferase domain (residue 42-356) was labeled in cyan, and the two PAPS binding sites (residue 49-55 and 202-210) were labeled in carmine.